# Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults

> **NCT01859143** · PHASE4 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 300 (actual)

## Conditions studied

- Influenza
- Healthy

## Interventions

- **BIOLOGICAL:** Trivalent Influenza Vaccine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01859143
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2014-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01859143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01859143, "Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01859143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*